advertisement

Topcon

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (7)

Showing records 1 to 7

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
23547 Ocular surface disfunction in glaucoma
Stefan C; Dumitrica DM
Oftalmologia 2008; 52: 114-119
23462 Polymeric nanoparticulate system: A potential approach for ocular drug delivery
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
Journal of Controlled Release 2009; 136: 2-13
23594 The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies
Flach AJ
Transactions of the American Ophthalmological Society 2008; 106:- 138-145; discussion 145-148
23953 Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage
Pauly A; Meloni M; Brignole-Baudouin F; Warnet JM; Baudouin C
Investigative Ophthalmology and Visual Science 2009; 50: 1644-1652
23933 The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant
Huhtala A; Rönkkö S; Teräsvirta M; Puustjärvi T; Sihvola R; Vehanen K; Laukkanen A; Anttila J; Urtti A; Pohjonen T
Investigative Ophthalmology and Visual Science 2009; 50: 2216-2223
23840 Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina
Mizuno K; Koide T; Shimada S; Mori J; Sawanobori K; Araie M
Investigative Ophthalmology and Visual Science 2009; 50: 2839-2847
23773 An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I
American Journal of Ophthalmology 2009; 147: 725-735

Issue 11-2

Change Issue


advertisement

Oculus